Radiological Diagnosis of Pulmonary Aspergillosis

François Laurent; Ilyes Benlala; Gael Dournes

doi:10.1055/s-0043-1776998

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2024; 45(01): 050-060
DOI: 10.1055/s-0043-1776998

Review Article

Radiological Diagnosis of Pulmonary Aspergillosis

François Laurent

¹Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France

,

Ilyes Benlala

¹Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France

²CHU Bordeaux, Service d'Imagerie Thoracique et Cardiovasculaire, Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France

,

Gael Dournes

¹Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France

²CHU Bordeaux, Service d'Imagerie Thoracique et Cardiovasculaire, Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France

› Institutsangaben

Abstract

Imaging plays an important role in the various forms of Aspergillus-related pulmonary disease. Depending on the immune status of the patient, three forms are described with distinct imaging characteristics: invasive aspergillosis affecting severely immunocompromised patients, chronic pulmonary aspergillosis affecting less severely immunocompromised patients but suffering from a pre-existing structural lung disease, and allergic bronchopulmonary aspergillosis related to respiratory exposure to Aspergillus species in patients with asthma and cystic fibrosis. Computed tomography (CT) has been demonstrated more sensitive and specific than chest radiographs and its use has largely contributed to the diagnosis, follow-up, and evaluation of treatment in each condition. In the last few decades, CT has also been described in the specific context of cystic fibrosis. In this particular clinical setting, magnetic resonance imaging and the recent developments in artificial intelligence have shown promising results.

Keywords

lung - aspergillosis - cystic fibrosis - imaging - computed tomography - magnetic resonance imaging

Volltext

Referenzen

References
1 Bergeron A, Porcher R, Sulahian A. et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood 2012; 119 (08) 1831-1837 , quiz 1956
2 Stemler J, Bruns C, Mellinghoff SC. et al. Baseline chest computed tomography as standard of care in high-risk hematology patients. J Fungi (Basel) 2020; 6 (01) 36
3 De Pauw B, Walsh TJ, Donnelly JP. et al; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46 (12) 1813-1821
4 Donnelly JP, Chen SC, Kauffman CA. et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 2020; 71 (06) 1367-1376
5 Ullmann AJ, Aguado JM, Arikan-Akdagli S. et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 2018; 24 (Suppl. 01) e1-e38
6 Raveendran S, Lu Z. CT findings and differential diagnosis in adults with invasive pulmonary aspergillosis. Radiol Infect Dis 2018; 5 (01) 14-25
7 Franquet T, Müller NL, Giménez A, Guembe P, de La Torre J, Bagué S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 2001; 21 (04) 825-837
8 Pasmans HLM, Loosveld OJL, Schouten HC, Thunnissen F, van Engelshoven JMA. Invasive aspergillosis in immunocompromised patients: findings on plain film and (HR)CT. Eur J Radiol 1992; 14 (01) 37-40
9 Park SY, Kim S-H, Choi S-H. et al. Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients. Transpl Infect Dis 2010; 12 (04) 309-315
10 Lim C, Seo JB, Park S-Y. et al. Analysis of initial and follow-up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation. Clin Radiol 2012; 67 (12) 1179-1186
11 Nam BD, Kim TJ, Lee KS, Kim TS, Han J, Chung MJ. Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings. Eur Radiol 2018; 28 (02) 788-795
12 Jung J, Kim MY, Lee HJ. et al. Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis. Clin Microbiol Infect 2015; 21 (07) 684.e11-684.e18
13 Marchiori E, Zanetti G, Escuissato DL. et al. Reversed halo sign: high-resolution CT scan findings in 79 patients. Chest 2012; 141 (05) 1260-1266
14 Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis 2011; 52 (09) 1144-1155
15 Henzler C, Henzler T, Buchheidt D. et al. Diagnostic performance of contrast enhanced pulmonary computed tomography angiography for the detection of angioinvasive pulmonary aspergillosis in immunocompromised patients. Sci Rep 2017; 7 (01) 4483
16 Burgos A, Zaoutis TE, Dvorak CC. et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008; 121 (05) e1286-e1294
17 Herbrecht R, Guffroy B, Danion F, Venkatasamy A, Simand C, Ledoux M-P. Validation by real-life data of the new radiological criteria of the revised and updated consensus definition for invasive fungal diseases. Clin Infect Dis 2020; 71 (10) 2773-2774
18 Desai SR, Hedayati V, Patel K, Hansell DM. Chronic aspergillosis of the lungs: unravelling the terminology and radiology. Eur Radiol 2015; 25 (10) 3100-3107
19 Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. “Semi-invasive” pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung. Radiology 1981; 140 (02) 313-321
20 Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37 (Suppl. 03) S265-S280
21 Denning DW, Cadranel J, Beigelman-Aubry C. et al. European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 2016; 47 (01) 45-68
22 Muldoon EG, Sharman A, Page I, Bishop P, Denning DW. Aspergillus nodules; another presentation of chronic pulmonary aspergillosis. BMC Pulm Med 2016; 16 (01) 123
23 Hot A, Maunoury C, Poiree S. et al. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect 2011; 17 (03) 409-417
24 Dournes G, Macey J, Blanchard E, Berger P, Laurent F. MRI of the pulmonary parenchyma: Towards clinical applicability? [in French]. Rev Pneumol Clin 2017; 73 (01) 40-49
25 Khalil A, Fedida B, Parrot A, Haddad S, Fartoukh M, Carette M-F. Severe hemoptysis: from diagnosis to embolization. Diagn Interv Imaging 2015; 96 (7–8): 775-788
26 Shin B, Koh W-J, Shin SW. et al. Outcomes of bronchial artery embolization for life-threatening hemoptysis in patients with chronic pulmonary aspergillosis. PLoS One 2016; 11 (12) e0168373
27 Osaki S, Nakanishi Y, Wataya H. et al. Prognosis of bronchial artery embolization in the management of hemoptysis. Respiration 2000; 67 (04) 412-416
28 Agarwal R, Vishwanath G, Aggarwal AN, Garg M, Gupta D, Chakrabarti A. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses 2013; 56 (05) 559-570
29 Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 2010; 51 (12) 1383-1391
30 Cadranel J, Philippe B, Hennequin C. et al. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis 2012; 31 (11) 3231-3239
31 Godet C, Laurent F, Bergeron A. et al; ACHROSCAN Study Group. CT imaging assessment of response to treatment in chronic pulmonary aspergillosis. Chest 2016; 150 (01) 139-147
32 Uzunhan Y, Nunes H, Jeny F. et al. Chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J 2017; 49 (06) 1602396
33 Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol 2012; 4 (04) 141-150
34 Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011; 20 (121) 156-174
35 Stevens DA, Moss RB, Kurup VP. et al; Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis–state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 (Suppl. 03) S225-S264
36 Breuer O, Schultz A, Garratt LW. et al. Aspergillus infections and progression of structural lung disease in children with cystic fibrosis. Am J Respir Crit Care Med 2020; 201 (06) 688-696
37 Brandt C, Roehmel J, Rickerts V, Melichar V, Niemann N, Schwarz C. Aspergillus bronchitis in patients with cystic fibrosis. Mycopathologia 2018; 183 (01) 61-69
38 Mastella G, Rainisio M, Harms HK. et al; Epidemiologic Registry of Cystic Fibrosis. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Respir J 2000; 16 (03) 464-471
39 Ward S, Heyneman L, Lee MJ, Leung AN, Hansell DM, Müller NL. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 1999; 173 (04) 937-942
40 Neeld DA, Goodman LR, Gurney JW, Greenberger PA, Fink JN. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1990; 142 (05) 1200-1205
41 Logan PM, Müller NL. High-attenuation mucous plugging in allergic bronchopulmonary aspergillosis. Can Assoc Radiol J 1996; 47 (05) 374-377
42 Refait J, Macey J, Bui S. et al. CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis. J Cyst Fibros 2019; 18 (04) e31-e36
43 Dournes G, Menut F, Macey J. et al. Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution. Eur Radiol 2016; 26 (11) 3811-3820
44 Longuefosse A, Raoult J, Benlala I. et al. Generating high-resolution synthetic CT from lung MRI with ultrashort echo times: initial evaluation in cystic fibrosis. Radiology 2023; 308 (01) e230052
45 Dournes G, Walkup LL, Benlala I. et al. The clinical use of lung MRI in cystic fibrosis: what, now, how?. Chest 2021; 159 (06) 2205-2217
46 Benlala I, Hocke F, Macey J. et al. Quantification of MRI T2-weighted high signal volume in cystic fibrosis: a pilot study. Radiology 2020; 294 (01) 186-196
47 Wielpütz MO, Puderbach M, Kopp-Schneider A. et al. Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2014; 189 (08) 956-965
48 Willmering MM, Walkup LL, Niedbalski PJ. et al. Pediatric ¹²⁹ Xe gas-transfer MRI-feasibility and applicability. J Magn Reson Imaging 2022; 56 (04) 1207-1219
49 Benlala I, Klaar R, Gaass T. et al. Non-contrast-enhanced functional lung MRI to evaluate treatment response of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a pilot study. J Magn Reson Imaging 2023; (e-pub ahead of print).
50 Dournes G, Berger P, Refait J. et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: MR imaging of airway mucus contrasts as a tool for diagnosis. Radiology 2017; 285 (01) 261-269
51 Agarwal R, Chakrabarti A, Shah A. et al; ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013; 43 (08) 850-873
52 Sunman B, Ademhan Tural D, Ozsezen B, Emiralioglu N, Yalcin E, Özçelik U. Current approach in the diagnosis and management of allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Front Pediatr 2020; 8: 582964
53 Brenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med 2007; 357 (22) 2277-2284
54 Pearce MS, Salotti JA, Little MP. et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380 (9840) 499-505